GI Dynamics Inc  

(Public, ASX:GID)   Watch this stock  
Find more results for Timothy Switzer�
0.000 (0.00%)
Mar 30 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range     -
52 week 0.12 - 0.64
Open     -
Vol / Avg. 0.00/988,461.00
Mkt cap 65.86M
P/E     -
Div/yield     -
EPS -0.13
Shares 94.80M
Beta     -
Inst. own     -
May 22, 2015
GI Dynamics Inc Annual Shareholders Meeting (Estimated) - 9:00AM GMT+10 - Add to calendar
Mar 6, 2015
GI Dynamics, Inc Investor Communication Call - Webcast
Jan 12, 2015
GI Dynamics, Inc at JPMorgan Healthcare Conference

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -2979.70% -1704.56%
Operating margin -2908.24% -1704.03%
EBITD margin - -1680.83%
Return on average assets -85.68% -74.84%
Return on average equity -99.94% -85.65%
Employees 38 -
CDP Score - -


United States - Map
+1-781-3573310 (Phone)
+1-781-3573301 (Fax)

Website links


GI Dynamics, Inc. designs, develops, and markets medical devices for non-surgical approaches to treating type 2 diabetes and obesity. The Company has commercially launched its lead product, the EndoBarrier. EndoBarrier Therapy is a treatment for people whose diabetes medications are no longer effective, who are at risk for serious health complications from their diabetes and excess weight and who want to avoid surgery or the progression to injectable therapy. The Company�s product is sold to customers located in Europe, the Middle East, Australia and South America. The Company is focused on the commercial rollout of the EndoBarrier in selected countries in Europe and South America, as well as in Australia and Israel. In the United States, it has received approval from the United States Food and Drug Administration (FDA), to commence its clinical trial, which began in 2013.

Officers and directors

Andy Levine Chief Technology Officer
Age: 54
Karl-Heinz Blohm Ph.D. Vice President - International Sales
Sherrie Coval-Goldsmith Vice President - Clinical and Regulatory Affairs
Anthony Tremaglio Senior Director of Marketing
Gerd Gottschalk Reimbursement Director
David Maggs M.D. Chief Medical Officer
Age: 47
Anthony Switzer Commercial Development - Australia
Michael Donald Dale President, Chief Executive Officer, Director
Age: 54
Jack Edward Meyer Independent Non-Executive Chairman of the Board
Age: 63
Michael A. Carusi Non-Independent Non-Executive Director